✦ LIBER ✦

Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial

✍ Scribed by B.L.D.M. Brücher; H.J. Stein; F. Zimmermann; M. Werner; M. Sarbia; R. Busch; H.J. Dittler; M. Molls; U. Fink; J.R. Siewert

Book ID: 116442290
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 191 KB
Volume: 30
Category: Article
ISSN: 0748-7983
DOI: 10.1016/j.ejso.2004.06.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Failure of the perioperative PCV neoadju

Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non-small cell carcinoma results from a randomized phase II trial

✍ Bertrand Dautzenberg; Jacques Benichou; Philippe Allard; Bernard Lebeau; Daniel 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Prospective phase II trial of cetuximab

Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma

✍ F. Alongi; M. Bignardi; I. Garassino; S. Pentimalli; R. Cavina; P. Mancosu; G. R 📂 Article 📅 2011 🏛 Springer 🌐 German ⚖ 419 KB

Neoadjuvant continuous infusion of weekl

Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial

✍ Lorenzen, S; Brücher, B; Zimmermann, F; Geinitz, H; Riera, J; Schuster, T; Roeth 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB

A prospective phase II trial of ONYX-015

A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the baylor experience)

✍ Jeffery P. Lamont; John Nemunaitis; Joseph A. Kuhn; Steven A. Landers; Todd M. M 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 576 KB

Alternating chemoradiotherapy versus par

Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck : Results from a phase III randomized trial

✍ Renzo Corvò; Marco Benasso; Giuseppe Sanguineti; Rita Lionetto; Almalina Bacigal 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

## BACKGROUND. The authors previously have found that in patients with locally advanced squamous cell carcinoma of the head and neck (SCC-HN), alternating chemoradiotherapy (ALT) was superior to low-total-dose conventional radiotherapy alone. The purpose of this randomized trial was to compare the

Results of phase I-II trial of concomita

Results of phase I-II trial of concomitant hyperfractionated radiation and oral etoposide (VP-16) in patients with unresectable squamous cell carcinoma of the head and neck

✍ Avi Khafif; Vikki A. Canfield; Elizabeth J. Syzek; Jesus E. Medina 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 64 KB